# Ambiotis jobs and careers

> 0 open roles at Ambiotis as of October 23, 2026. Source: https://www.thejobsmap.com/company/ambiotis

Ambiotis is a pre-clinical CRO specialized in the study of inflammatory processes and the active end of inflammation, called resolution. Resolution is now recognized as the necessary biological process to stop inflammation and restore homeostasis in tissues. This recent approach makes possible to study the inflammation process in a completely innovative and differentiating way. Ambiotis proposes services adapted to pharmaceutical, dermo-cosmetic, agro- food/nutraceutical industries to evaluate the potential of their molecules at preclinical or clinical stages of development. Ambiotis thus helps them to put faster on the market more efficient and innovative compounds on immuno-inflammatory processes. With more than 10 years of experience, Ambiotis has acquired a solid expertise in understanding the molecular mechanisms controlling these phenomenons . Ambiotis has built a strong expertise in both cell/animal models and analytical measurement. This combination is the key to ensure a full understanding and provide proof of efficacy or proof of concept for the development of new innovative products.

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Headquarters | France |
| Employees | 11 to 50 |
| Website | https://ambiotis.com |

## Leadership

- Marc Dubourdeau, Président - Directeur scientifique

## Common questions

### Is Ambiotis hiring right now?

Ambiotis has no open roles listed as of October 23, 2026. Roles appear here as soon as they are posted on Ambiotis's careers site.

### Where is Ambiotis headquartered?

Ambiotis is headquartered in France.

### Who leads Ambiotis?

Marc Dubourdeau, Président - Directeur scientifique, is at the top of Ambiotis's org chart.

### How do I apply for a job at Ambiotis?

Pick a role on Ambiotis's TheJobsMap page and select Apply. Every listing links to the original posting on Ambiotis's own careers site, so you apply directly with the employer.